73.20.Z - Market research and public opinion polling
58.11.Z - Book publishing
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
82.99.Z - Other business support service activities not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,5 | -0 | 0 | 4559,2 |
Gross profit (loss) | 0,1 | 0,2 | 0,2 | 17,5 |
EBITDA | 1 | 0,9 | 0,8 | -10,8 |
Short time liabilities | 1,5 | 1,5 | 1,1 | -21,5 |
Other operating costs | 0 | 0,3 | 0,1 | -73 |
Equity capital | 4 | 4,1 | 4,4 | 6,5 |
Operating profit (EBIT) | 0,1 | 0,2 | 0,3 | 21,1 |
Assets | 7,4 | 6,2 | 7,4 | 18,4 |
Net profit (loss) | 0,1 | 0,2 | 0,2 | 17,5 |
Cash | 0,7 | 0,6 | 0,9 | 58,9 |
Net income from sale | 7 | 6,5 | 6,9 | 5,1 |
Liabilities and provisions for liabilities | 3,5 | 2,1 | 3 | 42,1 |
Working assets | 2,7 | 1,8 | 1,5 | -16 |
Other income costs | 0,6 | 0,5 | 0,3 | -37,5 |
Depreciation | 0,9 | 0,7 | 0,5 | -22 |
% | % | % | p.p. | |
Profitability of capital | 1,8 | 4,3 | 4,8 | 0,5 |
Equity capital to total assets | 53,4 | 66,5 | 59,8 | -6,7 |
Gross profit margin | 1 | 2,7 | 3,1 | 0,4 |
EBITDA Margin | 14,2 | 13,8 | 11,7 | -2,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 80 | 82 | 61 | -21 |
Current financial liquidity indicator | 1.7608858346939087 | 1.2272372245788574 | 1.3123823404312134 | 0,1 |
Net dept to EBITDA | 0.041484538465738297 | -0.23710288107395172 | -0.3572086989879608 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane